CS219325B2 - Method of isolation of the polysaccharide - Google Patents
Method of isolation of the polysaccharide Download PDFInfo
- Publication number
- CS219325B2 CS219325B2 CS772085A CS208577A CS219325B2 CS 219325 B2 CS219325 B2 CS 219325B2 CS 772085 A CS772085 A CS 772085A CS 208577 A CS208577 A CS 208577A CS 219325 B2 CS219325 B2 CS 219325B2
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- extraction
- solution
- nitrogen
- coriolus
- water
- Prior art date
Links
- 229920001282 polysaccharide Polymers 0.000 title claims abstract description 23
- 239000005017 polysaccharide Substances 0.000 title claims abstract description 23
- 238000000034 method Methods 0.000 title claims description 21
- 150000004676 glycans Chemical class 0.000 title claims description 6
- 238000002955 isolation Methods 0.000 title claims description 6
- 241000233866 Fungi Species 0.000 claims abstract description 18
- 241000222356 Coriolus Species 0.000 claims abstract description 17
- 230000000259 anti-tumor effect Effects 0.000 claims abstract description 12
- 238000000605 extraction Methods 0.000 claims description 74
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 53
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 18
- 229910052757 nitrogen Inorganic materials 0.000 claims description 14
- 241000221198 Basidiomycota Species 0.000 claims description 11
- 239000003125 aqueous solvent Substances 0.000 claims description 8
- 241000222355 Trametes versicolor Species 0.000 claims description 7
- 230000000644 propagated effect Effects 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 27
- -1 nitrogen-containing polysaccharide Chemical class 0.000 abstract description 17
- 239000012670 alkaline solution Substances 0.000 abstract description 7
- 239000000243 solution Substances 0.000 description 41
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 13
- 206010028980 Neoplasm Diseases 0.000 description 10
- 238000005406 washing Methods 0.000 description 10
- 241000699670 Mus sp. Species 0.000 description 9
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 8
- 239000000284 extract Substances 0.000 description 8
- 239000000843 powder Substances 0.000 description 8
- 239000007858 starting material Substances 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 239000000047 product Substances 0.000 description 7
- 239000003513 alkali Substances 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 238000001816 cooling Methods 0.000 description 6
- 230000005764 inhibitory process Effects 0.000 description 6
- 238000007912 intraperitoneal administration Methods 0.000 description 6
- 229910052760 oxygen Inorganic materials 0.000 description 6
- 208000006268 Sarcoma 180 Diseases 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 5
- 150000001720 carbohydrates Chemical class 0.000 description 5
- 235000014633 carbohydrates Nutrition 0.000 description 5
- 229910052799 carbon Inorganic materials 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 238000000921 elemental analysis Methods 0.000 description 5
- 229910052739 hydrogen Inorganic materials 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 241000894007 species Species 0.000 description 4
- 241000222341 Polyporaceae Species 0.000 description 3
- 239000002246 antineoplastic agent Substances 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 238000000502 dialysis Methods 0.000 description 3
- 238000004108 freeze drying Methods 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 230000003285 pharmacodynamic effect Effects 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- KJCVRFUGPWSIIH-UHFFFAOYSA-N 1-naphthol Chemical compound C1=CC=C2C(O)=CC=CC2=C1 KJCVRFUGPWSIIH-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- 206010039491 Sarcoma Diseases 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 230000002538 fungal effect Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000006386 neutralization reaction Methods 0.000 description 2
- KWYUFKZDYYNOTN-UHFFFAOYSA-M potassium hydroxide Inorganic materials [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- FIHZWZBEAXASKA-UHFFFAOYSA-N Anthron Natural products COc1cc2Cc3cc(C)cc(O)c3C(=O)c2c(O)c1C=CC(C)C FIHZWZBEAXASKA-UHFFFAOYSA-N 0.000 description 1
- 241000974482 Aricia saepiolus Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000222357 Trametes hirsuta Species 0.000 description 1
- 241001676647 Trametes pubescens Species 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001371 alpha-amino acids Chemical class 0.000 description 1
- 235000008206 alpha-amino acids Nutrition 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 238000010936 aqueous wash Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- ASCHNMXUWBEZDM-UHFFFAOYSA-N chloridodioxygen(.) Chemical compound [O]OCl ASCHNMXUWBEZDM-UHFFFAOYSA-N 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000012065 filter cake Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000010200 folin Substances 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- OQUKIQWCVTZJAF-UHFFFAOYSA-N phenol;sulfuric acid Chemical compound OS(O)(=O)=O.OC1=CC=CC=C1 OQUKIQWCVTZJAF-UHFFFAOYSA-N 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000003439 radiotherapeutic effect Effects 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 238000001223 reverse osmosis Methods 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- 230000001235 sensitizing effect Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000005199 ultracentrifugation Methods 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/005—Glycopeptides, glycoproteins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Mycology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Engineering & Computer Science (AREA)
- Botany (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Alternative & Traditional Medicine (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Plant Substances (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8066576A JPS536413A (en) | 1976-07-07 | 1976-07-07 | Preparation of n-containing polysaccharides |
Publications (1)
Publication Number | Publication Date |
---|---|
CS219325B2 true CS219325B2 (en) | 1983-03-25 |
Family
ID=13724651
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CS772085A CS219325B2 (en) | 1976-07-07 | 1977-03-29 | Method of isolation of the polysaccharide |
Country Status (28)
Country | Link |
---|---|
US (1) | US4229570A (es) |
JP (1) | JPS536413A (es) |
AR (1) | AR217256A1 (es) |
AT (1) | AT360146B (es) |
AU (1) | AU497397B2 (es) |
BE (1) | BE853178A (es) |
BG (1) | BG33008A3 (es) |
BR (1) | BR7704434A (es) |
CA (1) | CA1072033A (es) |
CH (1) | CH628245A5 (es) |
CS (1) | CS219325B2 (es) |
DD (1) | DD130662A5 (es) |
DE (1) | DE2713536C2 (es) |
DK (1) | DK145424C (es) |
ES (1) | ES457723A1 (es) |
FR (1) | FR2361909A1 (es) |
GB (1) | GB1570538A (es) |
HU (1) | HU176828B (es) |
IN (1) | IN144759B (es) |
IT (1) | IT1075830B (es) |
MX (1) | MX4255E (es) |
NL (1) | NL169197C (es) |
PH (1) | PH12619A (es) |
PL (1) | PL103468B1 (es) |
SE (1) | SE441893B (es) |
SU (1) | SU704431A3 (es) |
YU (1) | YU39796B (es) |
ZA (1) | ZA773441B (es) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS536412A (en) * | 1976-07-07 | 1978-01-20 | Kureha Chem Ind Co Ltd | Preparation of n-containing polysaccharides |
US4851395A (en) * | 1976-07-07 | 1989-07-25 | Kureha Kagaku Kogyo Kabushiki Kausha | Nitrogen-containing polysaccharide |
JPS5315495A (en) * | 1976-07-22 | 1978-02-13 | Kureha Chem Ind Co Ltd | Preparation of polysaccharides |
JPS5394012A (en) * | 1977-01-27 | 1978-08-17 | Kureha Chem Ind Co Ltd | Novel polysaccharide and its preparation |
JPS5932480B2 (ja) * | 1981-02-10 | 1984-08-09 | 呉羽化学工業株式会社 | 新規な糖蛋白複合体 |
US4614733A (en) * | 1981-12-31 | 1986-09-30 | Kureha Kagaku Kogyo Kabushiki Kaisha | Polysaccharides pharmaceutical compositions and the use thereof |
DE3448153C2 (es) * | 1983-08-11 | 1989-11-02 | Kureha Kagaku Kogyo K.K., Nihonbashi, Tokio/Tokyo, Jp | |
JPH0643336B2 (ja) * | 1988-06-30 | 1994-06-08 | 呉羽化学工業株式会社 | 血管増殖抑制剤 |
GB2304347A (en) * | 1995-08-11 | 1997-03-19 | Boeringer Ingelheim Vetmedica | Antigenic preparations |
US7048932B2 (en) * | 2002-05-22 | 2006-05-23 | The Chinese University Of Hong Kong | Preparation and standardization of immunomodulatory peptide-linked glucans with verifiable oral absorbability from coriolus versicolor |
JPWO2005095413A1 (ja) * | 2004-04-01 | 2008-02-21 | 株式会社クレハ | 抗腫瘍剤 |
US7829098B2 (en) | 2005-11-08 | 2010-11-09 | Vita Green Health Products Co., Ltd | Herbal powder extracts and methods of preparing and using the same |
CA2812886C (en) * | 2010-10-06 | 2020-04-14 | Purapharm Company Limited | Coriolus versicolor extracts, methods of preparation and uses thereof |
CN104804107B (zh) * | 2015-04-24 | 2017-08-04 | 成都中医药大学 | 一种波棱瓜子多糖提取方法,该提取方法得到的波棱瓜子多糖提取物及用途 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3382229A (en) * | 1963-04-11 | 1968-05-07 | Exxon Production Research Co | Polysaccharide recovery process |
US3436311A (en) * | 1966-02-28 | 1969-04-01 | Pillsbury Co | Fungal polysaccharide composition and method for making same |
US3759896A (en) * | 1968-03-28 | 1973-09-18 | T Yamamoto | Process for manufacture of polysaccharides with antitumor action |
BE757248A (fr) * | 1969-10-15 | 1971-04-08 | Kureha Chemical Ind Co Ltd | Substance a propriete anticancereuse et procedes pour sa preparation |
US4051314A (en) * | 1970-10-14 | 1977-09-27 | Kureha Kagaku Kogyo Kabushiki Kaisha | Polysaccharides and method for producing same |
US3933788A (en) * | 1971-11-11 | 1976-01-20 | Kelco Company | Polysaccharide and bacterial fermentation process for its preparation |
JPS57793B2 (es) * | 1972-09-16 | 1982-01-07 | ||
JPS5290614A (en) * | 1975-12-18 | 1977-07-30 | Kureha Chem Ind Co Ltd | Preparation of anti-tumor substance |
PH14773A (en) * | 1976-01-01 | 1981-12-09 | Kureha Chemical Ind Co Ltd | Protein-bound polysaccharides |
JPS536412A (en) * | 1976-07-07 | 1978-01-20 | Kureha Chem Ind Co Ltd | Preparation of n-containing polysaccharides |
-
1976
- 1976-07-07 JP JP8066576A patent/JPS536413A/ja active Granted
-
1977
- 1977-03-22 YU YU764/77A patent/YU39796B/xx unknown
- 1977-03-22 SE SE7703264A patent/SE441893B/xx not_active IP Right Cessation
- 1977-03-26 DE DE2713536A patent/DE2713536C2/de not_active Expired
- 1977-03-28 IN IN463/CAL/77A patent/IN144759B/en unknown
- 1977-03-29 GB GB13270/77A patent/GB1570538A/en not_active Expired
- 1977-03-29 CS CS772085A patent/CS219325B2/cs unknown
- 1977-03-29 NL NLAANVRAGE7703371,A patent/NL169197C/xx not_active IP Right Cessation
- 1977-03-30 CA CA275,104A patent/CA1072033A/en not_active Expired
- 1977-03-30 AT AT219377A patent/AT360146B/de not_active IP Right Cessation
- 1977-04-01 BE BE176369A patent/BE853178A/xx not_active IP Right Cessation
- 1977-04-04 CH CH418077A patent/CH628245A5/de not_active IP Right Cessation
- 1977-04-05 DK DK151977A patent/DK145424C/da not_active IP Right Cessation
- 1977-04-05 FR FR7710262A patent/FR2361909A1/fr active Granted
- 1977-04-08 SU SU772468116A patent/SU704431A3/ru active
- 1977-04-12 ES ES457723A patent/ES457723A1/es not_active Expired
- 1977-04-12 AU AU24166/77A patent/AU497397B2/en not_active Expired
- 1977-04-13 DD DD7700198377A patent/DD130662A5/xx unknown
- 1977-04-13 PL PL1977197371A patent/PL103468B1/pl unknown
- 1977-04-15 IT IT22508/77A patent/IT1075830B/it active
- 1977-04-19 US US05/788,991 patent/US4229570A/en not_active Expired - Lifetime
- 1977-05-20 PH PH19794A patent/PH12619A/en unknown
- 1977-06-01 MX MX775769U patent/MX4255E/es unknown
- 1977-06-07 ZA ZA00773441A patent/ZA773441B/xx unknown
- 1977-06-17 AR AR268092A patent/AR217256A1/es active
- 1977-07-06 BR BR7704434A patent/BR7704434A/pt unknown
- 1977-07-06 BG BG7736818A patent/BG33008A3/xx unknown
- 1977-07-07 HU HU77KU517A patent/HU176828B/hu unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CS219880B2 (en) | Method of isolation of the polysaccharide | |
CS219325B2 (en) | Method of isolation of the polysaccharide | |
US4202885A (en) | Process for the preparation of anti-transplanted sarcoma 180 tumorigenic substances | |
US4289688A (en) | Protein-bound polysaccharides | |
DK144890B (da) | Fremgangsmaade til fremstilling af et nitrongenholdigt polysaccharid | |
EP0030812A2 (en) | A process for preparing substances having interferon inducing activity and interferon inducers | |
US4614733A (en) | Polysaccharides pharmaceutical compositions and the use thereof | |
CA1339308C (en) | Polysaccharides and antiviral drug containing polysaccharides as active ingredient | |
US4851395A (en) | Nitrogen-containing polysaccharide | |
US6120772A (en) | Oral drugs for treating AIDS patients | |
JP3129751B2 (ja) | ブナシメジ子実体熱水抽出物 | |
JPH0372085B2 (es) | ||
JPH01199593A (ja) | 抗ウイルス剤 | |
JPS6058925A (ja) | 抗腫瘍活性物質 | |
JPS6152807B2 (es) | ||
KR810001499B1 (ko) | 질소를 함유하는 다당류의 제조방법 | |
JPS6359679B2 (es) | ||
KR820000841B1 (ko) | 질소를 함유한 다당류의 제조방법 | |
JPH11209301A (ja) | 蛋白多糖体0041 | |
JPS6152806B2 (es) | ||
JPH054375B2 (es) | ||
JPS62130B2 (es) | ||
FR2499855A1 (fr) | Nouvelles substances a action carcinostatique et immuno-stimulante, procede pour les preparer a partir de bacteries du genre fusobacterium, et agent carcinostatique contenant de telles substances | |
JPS6018680B2 (ja) | 新規なる糖蛋白質prf,その製造法および該糖蛋白質を有効成分として含有する制癌剤 | |
JPS6213929B2 (es) |